Literature DB >> 29554194

LncRNAs in DNA damage response and repair in cancer cells.

Min Su1, Heran Wang1, Wenxiang Wang1, Ying Wang1, Linda Ouyang1, Chen Pan1, Longzheng Xia1, Deliang Cao1,2, Qianjin Liao1.   

Abstract

In order to maintain integrity of the genome, eukaryotic cells develop a complex DNA damage/repair response network, which can induce cell cycle arrest, apoptosis, or DNA repair. Chemo- and radiation therapies, which act primarily through the induction of DNA damage, are the most commonly used therapies for cancer. Impairment in the DNA damage response and repair system that protect cells from persistent DNA damage can affect the therapeutic efficacy of cancer. To date, accumulating evidence has suggested that long non-coding RNAs (lncRNAs) are involved in the regulation of the DNA damage/repair network. LncRNAs have been demonstrated to be master regulators of the genome at the transcriptional and post-transcriptional levels and play a key role in many physiological and pathological processes of cells. In this review, we will discuss the function of lncRNAs in regulating the cellular response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29554194     DOI: 10.1093/abbs/gmy022

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  9 in total

1.  LncRNAs of Saccharomyces cerevisiae bypass the cell cycle arrest imposed by ethanol stress.

Authors:  Lucas Cardoso Lázari; Ivan Rodrigo Wolf; Amanda Piveta Schnepper; Guilherme Targino Valente
Journal:  PLoS Comput Biol       Date:  2022-05-19       Impact factor: 4.779

2.  Overexpression of GIHCG is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma.

Authors:  Siyu Xiao; Shanzhou Huang; Jie Yang
Journal:  Onco Targets Ther       Date:  2020-11-12       Impact factor: 4.147

Review 3.  MiRNAs in Radiotherapy Resistance of Nasopharyngeal Carcinoma.

Authors:  Yutong Tian; Lu Tang; Pin Yi; Qing Pan; Yaqian Han; Yingrui Shi; Shan Rao; Shiming Tan; Longzheng Xia; Jinguan Lin; Linda Oyang; Yanyan Tang; Jiaxin Liang; Xia Luo; Qianjin Liao; Hui Wang; Yujuan Zhou
Journal:  J Cancer       Date:  2020-04-06       Impact factor: 4.207

Review 4.  The Biological Roles of lncRNAs and Future Prospects in Clinical Application.

Authors:  Guohui Li; Liang Deng; Nan Huang; Fenyong Sun
Journal:  Diseases       Date:  2021-01-13

5.  STAU2 protein level is controlled by caspases and the CHK1 pathway and regulates cell cycle progression in the non-transformed hTERT-RPE1 cells.

Authors:  Lionel Condé; Yulemi Gonzalez Quesada; Florence Bonnet-Magnaval; Rémy Beaujois; Luc DesGroseillers
Journal:  BMC Mol Cell Biol       Date:  2021-03-04

6.  miRNA and lncRNA Expression Networks Modulate Cell Cycle and DNA Repair Inhibition in Senescent Prostate Cells.

Authors:  Willian A da Silveira; Ludivine Renaud; Edward S Hazard; Gary Hardiman
Journal:  Genes (Basel)       Date:  2022-01-24       Impact factor: 4.096

Review 7.  Crosstalk between Long Non Coding RNAs, microRNAs and DNA Damage Repair in Prostate Cancer: New Therapeutic Opportunities?

Authors:  Folake Orafidiya; Lin Deng; Charlotte Lynne Bevan; Claire Emily Fletcher
Journal:  Cancers (Basel)       Date:  2022-01-31       Impact factor: 6.639

8.  LncRNA LINC01134 Contributes to Radioresistance in Hepatocellular Carcinoma by Regulating DNA Damage Response via MAPK Signaling Pathway.

Authors:  Zhiyi Wang; Xinxing Wang; Zhonghou Rong; Longfei Dai; Chengkun Qin; Shikang Wang; Wenmao Geng
Journal:  Front Pharmacol       Date:  2022-01-31       Impact factor: 5.810

9.  Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma.

Authors:  Yi Chen; Mengjia Huang; Junkai Zhu; Li Xu; Wenxuan Cheng; Xiaofan Lu; Fangrong Yan
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.